Created
October 23, 2019 18:04
-
-
Save DannyHinshaw/224c810718ccee10567d0a7deee76d6a to your computer and use it in GitHub Desktop.
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
export const AFINITOR = [{ | |
"TherapyContinuation_Plan": 173547, | |
"ProductName": "Afinitor", | |
"RxDed": 500, | |
"Month11_Patient": 500, | |
"Lives": 26088, | |
"TherapyInitiation_Patient": 1000, | |
"DrugTier": "4", | |
"MedDed": 6300, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 15777, | |
"PlanType": "EPO", | |
"Month11_Plan": 15777, | |
"Month8_Patient": 500, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 15777, | |
"Month6_Patient": 500, | |
"TherapyContinuation_Patient": 5500, | |
"TherapyInitiation_Plan": 15277, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 15777, | |
"Month2_Patient": 500, | |
"Month3_Plan": 15777, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 500, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D EPO", | |
"Month9_Plan": 15777, | |
"TotalPlanCost": 188824, | |
"Month9_Patient": 500, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 15777, | |
"Month8_Plan": 15777, | |
"Month7_Patient": 500, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6018, | |
"Month4_Plan": 15777, | |
"Month5_Patient": 500, | |
"Month7_Plan": 15777, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 15777, | |
"Month10_Patient": 500, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 178897, | |
"ProductName": "Afinitor", | |
"Month11_Patient": 0, | |
"Lives": 11891, | |
"TherapyInitiation_Patient": 6500, | |
"DrugTier": "4", | |
"MedDed": 6000, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16277, | |
"PlanType": "EPO", | |
"Month11_Plan": 16277, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16277, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 150, | |
"TherapyInitiation_Plan": 9777, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 16277, | |
"Month2_Patient": 150, | |
"Month3_Plan": 16277, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D HDHP EPO", | |
"Month9_Plan": 16277, | |
"TotalPlanCost": 188674, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 16127, | |
"Month8_Plan": 16277, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6019, | |
"Month4_Plan": 16277, | |
"Month5_Patient": 0, | |
"Month7_Plan": 16277, | |
"MedOOP": 6650, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 16277, | |
"Month10_Patient": 0, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 176897, | |
"ProductName": "Afinitor", | |
"Month11_Patient": 0, | |
"Lives": 782, | |
"TherapyInitiation_Patient": 5750, | |
"DrugTier": "4", | |
"MedDed": 5250, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 15777, | |
"PlanType": "EPO", | |
"Month11_Plan": 16277, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16277, | |
"Month6_Patient": 150, | |
"TherapyContinuation_Patient": 2150, | |
"TherapyInitiation_Plan": 10527, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 16127, | |
"Month2_Patient": 500, | |
"Month3_Plan": 15777, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5250", | |
"Month9_Plan": 16277, | |
"TotalPlanCost": 187424, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 15777, | |
"Month8_Plan": 16277, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6020, | |
"Month4_Plan": 15777, | |
"Month5_Patient": 500, | |
"Month7_Plan": 16277, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 16277, | |
"Month10_Patient": 0, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 177497, | |
"ProductName": "Afinitor", | |
"Month11_Patient": 0, | |
"Lives": 1773, | |
"TherapyInitiation_Patient": 6350, | |
"DrugTier": "4", | |
"MedDed": 5850, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16227, | |
"PlanType": "EPO", | |
"Month11_Plan": 16277, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16277, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1550, | |
"TherapyInitiation_Plan": 9927, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 16277, | |
"Month2_Patient": 500, | |
"Month3_Plan": 15777, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5850", | |
"Month9_Plan": 16277, | |
"TotalPlanCost": 187424, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 15777, | |
"Month8_Plan": 16277, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6021, | |
"Month4_Plan": 15777, | |
"Month5_Patient": 50, | |
"Month7_Plan": 16277, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 16277, | |
"Month10_Patient": 0, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 178547, | |
"ProductName": "Afinitor", | |
"Month11_Patient": 0, | |
"Lives": 1100, | |
"TherapyInitiation_Patient": 7400, | |
"DrugTier": "4", | |
"MedDed": 6900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16277, | |
"PlanType": "EPO", | |
"Month11_Plan": 16277, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16277, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 500, | |
"TherapyInitiation_Plan": 8877, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 16277, | |
"Month2_Patient": 500, | |
"Month3_Plan": 16277, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
"Month9_Plan": 16277, | |
"TotalPlanCost": 187424, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 15777, | |
"Month8_Plan": 16277, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6022, | |
"Month4_Plan": 16277, | |
"Month5_Patient": 0, | |
"Month7_Plan": 16277, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 16277, | |
"Month10_Patient": 0, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 176297, | |
"ProductName": "Afinitor", | |
"Month11_Patient": 250, | |
"Lives": 2373, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16027, | |
"PlanType": "EPO", | |
"Month11_Plan": 16027, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16027, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 16027, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 16027, | |
"Month2_Patient": 250, | |
"Month3_Plan": 16027, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Gold 80 D EPO", | |
"Month9_Plan": 16027, | |
"TotalPlanCost": 192324, | |
"Month9_Patient": 250, | |
"MetalLevel": "Gold", | |
"Month2_Plan": 16027, | |
"Month8_Plan": 16027, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6023, | |
"Month4_Plan": 16027, | |
"Month5_Patient": 250, | |
"Month7_Plan": 16027, | |
"MedOOP": 7200, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 16027, | |
"Month10_Patient": 250, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 179047, | |
"ProductName": "Afinitor", | |
"Month11_Patient": 0, | |
"Lives": 1594, | |
"TherapyInitiation_Patient": 7900, | |
"DrugTier": "4", | |
"MedDed": 7900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16277, | |
"PlanType": "EPO", | |
"Month11_Plan": 16277, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16277, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 0, | |
"TherapyInitiation_Plan": 8377, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 16277, | |
"Month2_Patient": 0, | |
"Month3_Plan": 16277, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"PlanName": "Anthem Minimum Coverage D EPO", | |
"Month9_Plan": 16277, | |
"TotalPlanCost": 187424, | |
"Month9_Patient": 0, | |
"MetalLevel": "Catastrophic", | |
"Month2_Plan": 16277, | |
"Month8_Plan": 16277, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6024, | |
"Month4_Plan": 16277, | |
"Month5_Patient": 0, | |
"Month7_Plan": 16277, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 16277, | |
"Month10_Patient": 0, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 176297, | |
"ProductName": "Afinitor", | |
"Month11_Patient": 250, | |
"Lives": 1040, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16027, | |
"PlanType": "EPO", | |
"Month11_Plan": 16027, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16027, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 16027, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 16027, | |
"Month2_Patient": 250, | |
"Month3_Plan": 16027, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Platinum 90 D EPO", | |
"Month9_Plan": 16027, | |
"TotalPlanCost": 192324, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 16027, | |
"Month8_Plan": 16027, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6025, | |
"Month4_Plan": 16027, | |
"Month5_Patient": 250, | |
"Month7_Plan": 16027, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 16027, | |
"Month10_Patient": 250, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 176297, | |
"ProductName": "Afinitor", | |
"RxDed": 200, | |
"Month11_Patient": 250, | |
"Lives": 44655, | |
"TherapyInitiation_Patient": 450, | |
"DrugTier": "4", | |
"MedDed": 2500, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16027, | |
"PlanType": "EPO", | |
"Month11_Plan": 16027, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16027, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 15827, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 16027, | |
"Month2_Patient": 250, | |
"Month3_Plan": 16027, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Silver 70 Off Exchange EPO", | |
"Month9_Plan": 16027, | |
"TotalPlanCost": 192124, | |
"Month9_Patient": 250, | |
"MetalLevel": "Silver", | |
"Month2_Plan": 16027, | |
"Month8_Plan": 16027, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6026, | |
"Month4_Plan": 16027, | |
"Month5_Patient": 250, | |
"Month7_Plan": 16027, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 16027, | |
"Month10_Patient": 250, | |
"DrugId": 2 | |
}, { | |
"TherapyContinuation_Plan": 177247, | |
"ProductName": "Afinitor", | |
"Month11_Patient": 0, | |
"Lives": 7081, | |
"TherapyInitiation_Patient": 6100, | |
"DrugTier": "4", | |
"MedDed": 5600, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 15977, | |
"PlanType": "PPO", | |
"Month11_Plan": 16277, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16277, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1800, | |
"TherapyInitiation_Plan": 10177, | |
"TotalTiers": "5", | |
"Month4_Patient": 500, | |
"Month6_Plan": 16277, | |
"Month2_Patient": 500, | |
"Month3_Plan": 15777, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze PPO 40/5600/40%", | |
"Month9_Plan": 16277, | |
"TotalPlanCost": 187424, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 15777, | |
"Month8_Plan": 16277, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6027, | |
"Month4_Plan": 15777, | |
"Month5_Patient": 300, | |
"Month7_Plan": 16277, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 16277, | |
"Month10_Patient": 0, | |
"DrugId": 2 | |
}]; | |
export const CABOMETYX = [{ | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"RxDed": 500, | |
"Month11_Patient": 17861, | |
"Lives": 26088, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 6300, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Bronze 60 D EPO", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6018, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"Month11_Patient": 17861, | |
"Lives": 11891, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 6000, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Bronze 60 D HDHP EPO", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6019, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 6650, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"Month11_Patient": 17861, | |
"Lives": 782, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 5250, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Bronze Pathway EPO 5250", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6020, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"Month11_Patient": 17861, | |
"Lives": 1773, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 5850, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Bronze Pathway EPO 5850", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6021, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"Month11_Patient": 17861, | |
"Lives": 1100, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 6900, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6022, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"Month11_Patient": 17861, | |
"Lives": 2373, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Gold 80 D EPO", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Gold", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6023, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 7200, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"Month11_Patient": 17861, | |
"Lives": 1594, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 7900, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Minimum Coverage D EPO", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Catastrophic", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6024, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"Month11_Patient": 17861, | |
"Lives": 1040, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Platinum 90 D EPO", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6025, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"RxDed": 200, | |
"Month11_Patient": 17861, | |
"Lives": 44655, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 2500, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "EPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "4", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Silver 70 Off Exchange EPO", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Silver", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6026, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}, { | |
"TherapyContinuation_Plan": 0, | |
"ProductName": "Cabometyx", | |
"Month11_Patient": 17861, | |
"Lives": 7081, | |
"TherapyInitiation_Patient": 17861, | |
"DrugTier": "Not Covered", | |
"MedDed": 5600, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 0, | |
"PlanType": "PPO", | |
"Month11_Plan": 0, | |
"Month8_Patient": 17861, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 0, | |
"Month6_Patient": 17861, | |
"TherapyContinuation_Patient": 196471, | |
"TherapyInitiation_Plan": 0, | |
"TotalTiers": "5", | |
"Month4_Patient": 17861, | |
"Month6_Plan": 0, | |
"Month2_Patient": 17861, | |
"Month3_Plan": 0, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 17861, | |
"PlanName": "Anthem Bronze PPO 40/5600/40%", | |
"Month9_Plan": 0, | |
"TotalPlanCost": 0, | |
"Month9_Patient": 17861, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 0, | |
"Month8_Plan": 0, | |
"Month7_Patient": 17861, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6027, | |
"Month4_Plan": 0, | |
"Month5_Patient": 17861, | |
"Month7_Plan": 0, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 17861, | |
"Month10_Plan": 0, | |
"Month10_Patient": 17861, | |
"DrugId": 87 | |
}]; | |
export const INLYTA = [{ | |
"TherapyContinuation_Plan": 144980, | |
"ProductName": "Inlyta", | |
"RxDed": 500, | |
"Month11_Patient": 500, | |
"Lives": 26088, | |
"TherapyInitiation_Patient": 1000, | |
"DrugTier": "4", | |
"MedDed": 6300, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13180, | |
"PlanType": "EPO", | |
"Month11_Plan": 13180, | |
"Month8_Patient": 500, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13180, | |
"Month6_Patient": 500, | |
"TherapyContinuation_Patient": 5500, | |
"TherapyInitiation_Plan": 12680, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 13180, | |
"Month2_Patient": 500, | |
"Month3_Plan": 13180, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 500, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D EPO", | |
"Month9_Plan": 13180, | |
"TotalPlanCost": 157660, | |
"Month9_Patient": 500, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 13180, | |
"Month8_Plan": 13180, | |
"Month7_Patient": 500, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6018, | |
"Month4_Plan": 13180, | |
"Month5_Patient": 500, | |
"Month7_Plan": 13180, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 13180, | |
"Month10_Patient": 500, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 150330, | |
"ProductName": "Inlyta", | |
"Month11_Patient": 0, | |
"Lives": 11891, | |
"TherapyInitiation_Patient": 6500, | |
"DrugTier": "4", | |
"MedDed": 6000, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13680, | |
"PlanType": "EPO", | |
"Month11_Plan": 13680, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13680, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 150, | |
"TherapyInitiation_Plan": 7180, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 13680, | |
"Month2_Patient": 150, | |
"Month3_Plan": 13680, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D HDHP EPO", | |
"Month9_Plan": 13680, | |
"TotalPlanCost": 157510, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 13530, | |
"Month8_Plan": 13680, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6019, | |
"Month4_Plan": 13680, | |
"Month5_Patient": 0, | |
"Month7_Plan": 13680, | |
"MedOOP": 6650, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 13680, | |
"Month10_Patient": 0, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 148330, | |
"ProductName": "Inlyta", | |
"Month11_Patient": 0, | |
"Lives": 782, | |
"TherapyInitiation_Patient": 5750, | |
"DrugTier": "4", | |
"MedDed": 5250, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13180, | |
"PlanType": "EPO", | |
"Month11_Plan": 13680, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13680, | |
"Month6_Patient": 150, | |
"TherapyContinuation_Patient": 2150, | |
"TherapyInitiation_Plan": 7930, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 13530, | |
"Month2_Patient": 500, | |
"Month3_Plan": 13180, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5250", | |
"Month9_Plan": 13680, | |
"TotalPlanCost": 156260, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 13180, | |
"Month8_Plan": 13680, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6020, | |
"Month4_Plan": 13180, | |
"Month5_Patient": 500, | |
"Month7_Plan": 13680, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 13680, | |
"Month10_Patient": 0, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 148930, | |
"ProductName": "Inlyta", | |
"Month11_Patient": 0, | |
"Lives": 1773, | |
"TherapyInitiation_Patient": 6350, | |
"DrugTier": "4", | |
"MedDed": 5850, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13630, | |
"PlanType": "EPO", | |
"Month11_Plan": 13680, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13680, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1550, | |
"TherapyInitiation_Plan": 7330, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 13680, | |
"Month2_Patient": 500, | |
"Month3_Plan": 13180, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5850", | |
"Month9_Plan": 13680, | |
"TotalPlanCost": 156260, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 13180, | |
"Month8_Plan": 13680, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6021, | |
"Month4_Plan": 13180, | |
"Month5_Patient": 50, | |
"Month7_Plan": 13680, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 13680, | |
"Month10_Patient": 0, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 149980, | |
"ProductName": "Inlyta", | |
"Month11_Patient": 0, | |
"Lives": 1100, | |
"TherapyInitiation_Patient": 7400, | |
"DrugTier": "4", | |
"MedDed": 6900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13680, | |
"PlanType": "EPO", | |
"Month11_Plan": 13680, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13680, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 500, | |
"TherapyInitiation_Plan": 6280, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 13680, | |
"Month2_Patient": 500, | |
"Month3_Plan": 13680, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
"Month9_Plan": 13680, | |
"TotalPlanCost": 156260, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 13180, | |
"Month8_Plan": 13680, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6022, | |
"Month4_Plan": 13680, | |
"Month5_Patient": 0, | |
"Month7_Plan": 13680, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 13680, | |
"Month10_Patient": 0, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 147730, | |
"ProductName": "Inlyta", | |
"Month11_Patient": 250, | |
"Lives": 2373, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13430, | |
"PlanType": "EPO", | |
"Month11_Plan": 13430, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13430, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 13430, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 13430, | |
"Month2_Patient": 250, | |
"Month3_Plan": 13430, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Gold 80 D EPO", | |
"Month9_Plan": 13430, | |
"TotalPlanCost": 161160, | |
"Month9_Patient": 250, | |
"MetalLevel": "Gold", | |
"Month2_Plan": 13430, | |
"Month8_Plan": 13430, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6023, | |
"Month4_Plan": 13430, | |
"Month5_Patient": 250, | |
"Month7_Plan": 13430, | |
"MedOOP": 7200, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 13430, | |
"Month10_Patient": 250, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 150480, | |
"ProductName": "Inlyta", | |
"Month11_Patient": 0, | |
"Lives": 1594, | |
"TherapyInitiation_Patient": 7900, | |
"DrugTier": "4", | |
"MedDed": 7900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13680, | |
"PlanType": "EPO", | |
"Month11_Plan": 13680, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13680, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 0, | |
"TherapyInitiation_Plan": 5780, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 13680, | |
"Month2_Patient": 0, | |
"Month3_Plan": 13680, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"PlanName": "Anthem Minimum Coverage D EPO", | |
"Month9_Plan": 13680, | |
"TotalPlanCost": 156260, | |
"Month9_Patient": 0, | |
"MetalLevel": "Catastrophic", | |
"Month2_Plan": 13680, | |
"Month8_Plan": 13680, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6024, | |
"Month4_Plan": 13680, | |
"Month5_Patient": 0, | |
"Month7_Plan": 13680, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 13680, | |
"Month10_Patient": 0, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 147730, | |
"ProductName": "Inlyta", | |
"Month11_Patient": 250, | |
"Lives": 1040, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13430, | |
"PlanType": "EPO", | |
"Month11_Plan": 13430, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13430, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 13430, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 13430, | |
"Month2_Patient": 250, | |
"Month3_Plan": 13430, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Platinum 90 D EPO", | |
"Month9_Plan": 13430, | |
"TotalPlanCost": 161160, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 13430, | |
"Month8_Plan": 13430, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6025, | |
"Month4_Plan": 13430, | |
"Month5_Patient": 250, | |
"Month7_Plan": 13430, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 13430, | |
"Month10_Patient": 250, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 147730, | |
"ProductName": "Inlyta", | |
"RxDed": 200, | |
"Month11_Patient": 250, | |
"Lives": 44655, | |
"TherapyInitiation_Patient": 450, | |
"DrugTier": "4", | |
"MedDed": 2500, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13430, | |
"PlanType": "EPO", | |
"Month11_Plan": 13430, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13430, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 13230, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 13430, | |
"Month2_Patient": 250, | |
"Month3_Plan": 13430, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Silver 70 Off Exchange EPO", | |
"Month9_Plan": 13430, | |
"TotalPlanCost": 160960, | |
"Month9_Patient": 250, | |
"MetalLevel": "Silver", | |
"Month2_Plan": 13430, | |
"Month8_Plan": 13430, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6026, | |
"Month4_Plan": 13430, | |
"Month5_Patient": 250, | |
"Month7_Plan": 13430, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 13430, | |
"Month10_Patient": 250, | |
"DrugId": 64 | |
}, { | |
"TherapyContinuation_Plan": 148680, | |
"ProductName": "Inlyta", | |
"Month11_Patient": 0, | |
"Lives": 7081, | |
"TherapyInitiation_Patient": 6100, | |
"DrugTier": "4", | |
"MedDed": 5600, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 13380, | |
"PlanType": "PPO", | |
"Month11_Plan": 13680, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 13680, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1800, | |
"TherapyInitiation_Plan": 7580, | |
"TotalTiers": "5", | |
"Month4_Patient": 500, | |
"Month6_Plan": 13680, | |
"Month2_Patient": 500, | |
"Month3_Plan": 13180, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze PPO 40/5600/40%", | |
"Month9_Plan": 13680, | |
"TotalPlanCost": 156260, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 13180, | |
"Month8_Plan": 13680, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6027, | |
"Month4_Plan": 13180, | |
"Month5_Patient": 300, | |
"Month7_Plan": 13680, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 13680, | |
"Month10_Patient": 0, | |
"DrugId": 64 | |
}]; | |
export const LENVIMA = [{ | |
"TherapyContinuation_Plan": 196218, | |
"ProductName": "Lenvima", | |
"RxDed": 500, | |
"Month11_Patient": 500, | |
"Lives": 26088, | |
"TherapyInitiation_Patient": 1000, | |
"DrugTier": "4", | |
"MedDed": 6300, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17838, | |
"PlanType": "EPO", | |
"Month11_Plan": 17838, | |
"Month8_Patient": 500, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17838, | |
"Month6_Patient": 500, | |
"TherapyContinuation_Patient": 5500, | |
"TherapyInitiation_Plan": 17338, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 17838, | |
"Month2_Patient": 500, | |
"Month3_Plan": 17838, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 500, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D EPO", | |
"Month9_Plan": 17838, | |
"TotalPlanCost": 213556, | |
"Month9_Patient": 500, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 17838, | |
"Month8_Plan": 17838, | |
"Month7_Patient": 500, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6018, | |
"Month4_Plan": 17838, | |
"Month5_Patient": 500, | |
"Month7_Plan": 17838, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 17838, | |
"Month10_Patient": 500, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 201568, | |
"ProductName": "Lenvima", | |
"Month11_Patient": 0, | |
"Lives": 11891, | |
"TherapyInitiation_Patient": 6500, | |
"DrugTier": "4", | |
"MedDed": 6000, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 18338, | |
"PlanType": "EPO", | |
"Month11_Plan": 18338, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18338, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 150, | |
"TherapyInitiation_Plan": 11838, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 18338, | |
"Month2_Patient": 150, | |
"Month3_Plan": 18338, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D HDHP EPO", | |
"Month9_Plan": 18338, | |
"TotalPlanCost": 213406, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 18188, | |
"Month8_Plan": 18338, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6019, | |
"Month4_Plan": 18338, | |
"Month5_Patient": 0, | |
"Month7_Plan": 18338, | |
"MedOOP": 6650, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 18338, | |
"Month10_Patient": 0, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 199568, | |
"ProductName": "Lenvima", | |
"Month11_Patient": 0, | |
"Lives": 782, | |
"TherapyInitiation_Patient": 5750, | |
"DrugTier": "4", | |
"MedDed": 5250, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17838, | |
"PlanType": "EPO", | |
"Month11_Plan": 18338, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18338, | |
"Month6_Patient": 150, | |
"TherapyContinuation_Patient": 2150, | |
"TherapyInitiation_Plan": 12588, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 18188, | |
"Month2_Patient": 500, | |
"Month3_Plan": 17838, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5250", | |
"Month9_Plan": 18338, | |
"TotalPlanCost": 212156, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 17838, | |
"Month8_Plan": 18338, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6020, | |
"Month4_Plan": 17838, | |
"Month5_Patient": 500, | |
"Month7_Plan": 18338, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 18338, | |
"Month10_Patient": 0, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 200168, | |
"ProductName": "Lenvima", | |
"Month11_Patient": 0, | |
"Lives": 1773, | |
"TherapyInitiation_Patient": 6350, | |
"DrugTier": "4", | |
"MedDed": 5850, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 18288, | |
"PlanType": "EPO", | |
"Month11_Plan": 18338, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18338, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1550, | |
"TherapyInitiation_Plan": 11988, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 18338, | |
"Month2_Patient": 500, | |
"Month3_Plan": 17838, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5850", | |
"Month9_Plan": 18338, | |
"TotalPlanCost": 212156, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 17838, | |
"Month8_Plan": 18338, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6021, | |
"Month4_Plan": 17838, | |
"Month5_Patient": 50, | |
"Month7_Plan": 18338, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 18338, | |
"Month10_Patient": 0, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 201218, | |
"ProductName": "Lenvima", | |
"Month11_Patient": 0, | |
"Lives": 1100, | |
"TherapyInitiation_Patient": 7400, | |
"DrugTier": "4", | |
"MedDed": 6900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 18338, | |
"PlanType": "EPO", | |
"Month11_Plan": 18338, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18338, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 500, | |
"TherapyInitiation_Plan": 10938, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 18338, | |
"Month2_Patient": 500, | |
"Month3_Plan": 18338, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
"Month9_Plan": 18338, | |
"TotalPlanCost": 212156, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 17838, | |
"Month8_Plan": 18338, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6022, | |
"Month4_Plan": 18338, | |
"Month5_Patient": 0, | |
"Month7_Plan": 18338, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 18338, | |
"Month10_Patient": 0, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 198968, | |
"ProductName": "Lenvima", | |
"Month11_Patient": 250, | |
"Lives": 2373, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 18088, | |
"PlanType": "EPO", | |
"Month11_Plan": 18088, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18088, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 18088, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 18088, | |
"Month2_Patient": 250, | |
"Month3_Plan": 18088, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Gold 80 D EPO", | |
"Month9_Plan": 18088, | |
"TotalPlanCost": 217056, | |
"Month9_Patient": 250, | |
"MetalLevel": "Gold", | |
"Month2_Plan": 18088, | |
"Month8_Plan": 18088, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6023, | |
"Month4_Plan": 18088, | |
"Month5_Patient": 250, | |
"Month7_Plan": 18088, | |
"MedOOP": 7200, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 18088, | |
"Month10_Patient": 250, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 201718, | |
"ProductName": "Lenvima", | |
"Month11_Patient": 0, | |
"Lives": 1594, | |
"TherapyInitiation_Patient": 7900, | |
"DrugTier": "4", | |
"MedDed": 7900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 18338, | |
"PlanType": "EPO", | |
"Month11_Plan": 18338, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18338, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 0, | |
"TherapyInitiation_Plan": 10438, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 18338, | |
"Month2_Patient": 0, | |
"Month3_Plan": 18338, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"PlanName": "Anthem Minimum Coverage D EPO", | |
"Month9_Plan": 18338, | |
"TotalPlanCost": 212156, | |
"Month9_Patient": 0, | |
"MetalLevel": "Catastrophic", | |
"Month2_Plan": 18338, | |
"Month8_Plan": 18338, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6024, | |
"Month4_Plan": 18338, | |
"Month5_Patient": 0, | |
"Month7_Plan": 18338, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 18338, | |
"Month10_Patient": 0, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 198968, | |
"ProductName": "Lenvima", | |
"Month11_Patient": 250, | |
"Lives": 1040, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 18088, | |
"PlanType": "EPO", | |
"Month11_Plan": 18088, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18088, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 18088, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 18088, | |
"Month2_Patient": 250, | |
"Month3_Plan": 18088, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Platinum 90 D EPO", | |
"Month9_Plan": 18088, | |
"TotalPlanCost": 217056, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 18088, | |
"Month8_Plan": 18088, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6025, | |
"Month4_Plan": 18088, | |
"Month5_Patient": 250, | |
"Month7_Plan": 18088, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 18088, | |
"Month10_Patient": 250, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 198968, | |
"ProductName": "Lenvima", | |
"RxDed": 200, | |
"Month11_Patient": 250, | |
"Lives": 44655, | |
"TherapyInitiation_Patient": 450, | |
"DrugTier": "4", | |
"MedDed": 2500, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 18088, | |
"PlanType": "EPO", | |
"Month11_Plan": 18088, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18088, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 17888, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 18088, | |
"Month2_Patient": 250, | |
"Month3_Plan": 18088, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Silver 70 Off Exchange EPO", | |
"Month9_Plan": 18088, | |
"TotalPlanCost": 216856, | |
"Month9_Patient": 250, | |
"MetalLevel": "Silver", | |
"Month2_Plan": 18088, | |
"Month8_Plan": 18088, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6026, | |
"Month4_Plan": 18088, | |
"Month5_Patient": 250, | |
"Month7_Plan": 18088, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 18088, | |
"Month10_Patient": 250, | |
"DrugId": 104 | |
}, { | |
"TherapyContinuation_Plan": 199918, | |
"ProductName": "Lenvima", | |
"Month11_Patient": 0, | |
"Lives": 7081, | |
"TherapyInitiation_Patient": 6100, | |
"DrugTier": "4", | |
"MedDed": 5600, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 18038, | |
"PlanType": "PPO", | |
"Month11_Plan": 18338, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 18338, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1800, | |
"TherapyInitiation_Plan": 12238, | |
"TotalTiers": "5", | |
"Month4_Patient": 500, | |
"Month6_Plan": 18338, | |
"Month2_Patient": 500, | |
"Month3_Plan": 17838, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze PPO 40/5600/40%", | |
"Month9_Plan": 18338, | |
"TotalPlanCost": 212156, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 17838, | |
"Month8_Plan": 18338, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6027, | |
"Month4_Plan": 17838, | |
"Month5_Patient": 300, | |
"Month7_Plan": 18338, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 18338, | |
"Month10_Patient": 0, | |
"DrugId": 104 | |
}]; | |
export const NEXAVAR = [{ | |
"TherapyContinuation_Plan": 209033, | |
"ProductName": "Nexavar", | |
"RxDed": 500, | |
"Month11_Patient": 500, | |
"Lives": 26088, | |
"TherapyInitiation_Patient": 1000, | |
"DrugTier": "4", | |
"MedDed": 6300, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19003, | |
"PlanType": "EPO", | |
"Month11_Plan": 19003, | |
"Month8_Patient": 500, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19003, | |
"Month6_Patient": 500, | |
"TherapyContinuation_Patient": 5500, | |
"TherapyInitiation_Plan": 18503, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 19003, | |
"Month2_Patient": 500, | |
"Month3_Plan": 19003, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 500, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D EPO", | |
"Month9_Plan": 19003, | |
"TotalPlanCost": 227536, | |
"Month9_Patient": 500, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 19003, | |
"Month8_Plan": 19003, | |
"Month7_Patient": 500, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6018, | |
"Month4_Plan": 19003, | |
"Month5_Patient": 500, | |
"Month7_Plan": 19003, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 19003, | |
"Month10_Patient": 500, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 214383, | |
"ProductName": "Nexavar", | |
"Month11_Patient": 0, | |
"Lives": 11891, | |
"TherapyInitiation_Patient": 6500, | |
"DrugTier": "4", | |
"MedDed": 6000, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19503, | |
"PlanType": "EPO", | |
"Month11_Plan": 19503, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19503, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 150, | |
"TherapyInitiation_Plan": 13003, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 19503, | |
"Month2_Patient": 150, | |
"Month3_Plan": 19503, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D HDHP EPO", | |
"Month9_Plan": 19503, | |
"TotalPlanCost": 227386, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 19353, | |
"Month8_Plan": 19503, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6019, | |
"Month4_Plan": 19503, | |
"Month5_Patient": 0, | |
"Month7_Plan": 19503, | |
"MedOOP": 6650, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 19503, | |
"Month10_Patient": 0, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 212383, | |
"ProductName": "Nexavar", | |
"Month11_Patient": 0, | |
"Lives": 782, | |
"TherapyInitiation_Patient": 5750, | |
"DrugTier": "4", | |
"MedDed": 5250, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19003, | |
"PlanType": "EPO", | |
"Month11_Plan": 19503, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19503, | |
"Month6_Patient": 150, | |
"TherapyContinuation_Patient": 2150, | |
"TherapyInitiation_Plan": 13753, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 19353, | |
"Month2_Patient": 500, | |
"Month3_Plan": 19003, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5250", | |
"Month9_Plan": 19503, | |
"TotalPlanCost": 226136, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 19003, | |
"Month8_Plan": 19503, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6020, | |
"Month4_Plan": 19003, | |
"Month5_Patient": 500, | |
"Month7_Plan": 19503, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 19503, | |
"Month10_Patient": 0, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 212983, | |
"ProductName": "Nexavar", | |
"Month11_Patient": 0, | |
"Lives": 1773, | |
"TherapyInitiation_Patient": 6350, | |
"DrugTier": "4", | |
"MedDed": 5850, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19453, | |
"PlanType": "EPO", | |
"Month11_Plan": 19503, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19503, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1550, | |
"TherapyInitiation_Plan": 13153, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 19503, | |
"Month2_Patient": 500, | |
"Month3_Plan": 19003, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5850", | |
"Month9_Plan": 19503, | |
"TotalPlanCost": 226136, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 19003, | |
"Month8_Plan": 19503, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6021, | |
"Month4_Plan": 19003, | |
"Month5_Patient": 50, | |
"Month7_Plan": 19503, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 19503, | |
"Month10_Patient": 0, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 214033, | |
"ProductName": "Nexavar", | |
"Month11_Patient": 0, | |
"Lives": 1100, | |
"TherapyInitiation_Patient": 7400, | |
"DrugTier": "4", | |
"MedDed": 6900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19503, | |
"PlanType": "EPO", | |
"Month11_Plan": 19503, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19503, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 500, | |
"TherapyInitiation_Plan": 12103, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 19503, | |
"Month2_Patient": 500, | |
"Month3_Plan": 19503, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
"Month9_Plan": 19503, | |
"TotalPlanCost": 226136, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 19003, | |
"Month8_Plan": 19503, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6022, | |
"Month4_Plan": 19503, | |
"Month5_Patient": 0, | |
"Month7_Plan": 19503, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 19503, | |
"Month10_Patient": 0, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 211783, | |
"ProductName": "Nexavar", | |
"Month11_Patient": 250, | |
"Lives": 2373, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19253, | |
"PlanType": "EPO", | |
"Month11_Plan": 19253, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19253, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 19253, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 19253, | |
"Month2_Patient": 250, | |
"Month3_Plan": 19253, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Gold 80 D EPO", | |
"Month9_Plan": 19253, | |
"TotalPlanCost": 231036, | |
"Month9_Patient": 250, | |
"MetalLevel": "Gold", | |
"Month2_Plan": 19253, | |
"Month8_Plan": 19253, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6023, | |
"Month4_Plan": 19253, | |
"Month5_Patient": 250, | |
"Month7_Plan": 19253, | |
"MedOOP": 7200, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 19253, | |
"Month10_Patient": 250, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 214533, | |
"ProductName": "Nexavar", | |
"Month11_Patient": 0, | |
"Lives": 1594, | |
"TherapyInitiation_Patient": 7900, | |
"DrugTier": "4", | |
"MedDed": 7900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19503, | |
"PlanType": "EPO", | |
"Month11_Plan": 19503, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19503, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 0, | |
"TherapyInitiation_Plan": 11603, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 19503, | |
"Month2_Patient": 0, | |
"Month3_Plan": 19503, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"PlanName": "Anthem Minimum Coverage D EPO", | |
"Month9_Plan": 19503, | |
"TotalPlanCost": 226136, | |
"Month9_Patient": 0, | |
"MetalLevel": "Catastrophic", | |
"Month2_Plan": 19503, | |
"Month8_Plan": 19503, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6024, | |
"Month4_Plan": 19503, | |
"Month5_Patient": 0, | |
"Month7_Plan": 19503, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 19503, | |
"Month10_Patient": 0, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 211783, | |
"ProductName": "Nexavar", | |
"Month11_Patient": 250, | |
"Lives": 1040, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19253, | |
"PlanType": "EPO", | |
"Month11_Plan": 19253, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19253, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 19253, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 19253, | |
"Month2_Patient": 250, | |
"Month3_Plan": 19253, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Platinum 90 D EPO", | |
"Month9_Plan": 19253, | |
"TotalPlanCost": 231036, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 19253, | |
"Month8_Plan": 19253, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6025, | |
"Month4_Plan": 19253, | |
"Month5_Patient": 250, | |
"Month7_Plan": 19253, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 19253, | |
"Month10_Patient": 250, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 211783, | |
"ProductName": "Nexavar", | |
"RxDed": 200, | |
"Month11_Patient": 250, | |
"Lives": 44655, | |
"TherapyInitiation_Patient": 450, | |
"DrugTier": "4", | |
"MedDed": 2500, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19253, | |
"PlanType": "EPO", | |
"Month11_Plan": 19253, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19253, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 19053, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 19253, | |
"Month2_Patient": 250, | |
"Month3_Plan": 19253, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Silver 70 Off Exchange EPO", | |
"Month9_Plan": 19253, | |
"TotalPlanCost": 230836, | |
"Month9_Patient": 250, | |
"MetalLevel": "Silver", | |
"Month2_Plan": 19253, | |
"Month8_Plan": 19253, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6026, | |
"Month4_Plan": 19253, | |
"Month5_Patient": 250, | |
"Month7_Plan": 19253, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 19253, | |
"Month10_Patient": 250, | |
"DrugId": 65 | |
}, { | |
"TherapyContinuation_Plan": 212733, | |
"ProductName": "Nexavar", | |
"Month11_Patient": 0, | |
"Lives": 7081, | |
"TherapyInitiation_Patient": 6100, | |
"DrugTier": "4", | |
"MedDed": 5600, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 19203, | |
"PlanType": "PPO", | |
"Month11_Plan": 19503, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 19503, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1800, | |
"TherapyInitiation_Plan": 13403, | |
"TotalTiers": "5", | |
"Month4_Patient": 500, | |
"Month6_Plan": 19503, | |
"Month2_Patient": 500, | |
"Month3_Plan": 19003, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze PPO 40/5600/40%", | |
"Month9_Plan": 19503, | |
"TotalPlanCost": 226136, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 19003, | |
"Month8_Plan": 19503, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6027, | |
"Month4_Plan": 19003, | |
"Month5_Patient": 300, | |
"Month7_Plan": 19503, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 19503, | |
"Month10_Patient": 0, | |
"DrugId": 65 | |
}]; | |
export const SUTENT = [{ | |
"TherapyContinuation_Plan": 185471, | |
"ProductName": "Sutent", | |
"RxDed": 500, | |
"Month11_Patient": 500, | |
"Lives": 26088, | |
"TherapyInitiation_Patient": 1000, | |
"DrugTier": "4", | |
"MedDed": 6300, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16861, | |
"PlanType": "EPO", | |
"Month11_Plan": 16861, | |
"Month8_Patient": 500, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 16861, | |
"Month6_Patient": 500, | |
"TherapyContinuation_Patient": 5500, | |
"TherapyInitiation_Plan": 16361, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 16861, | |
"Month2_Patient": 500, | |
"Month3_Plan": 16861, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 500, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D EPO", | |
"Month9_Plan": 16861, | |
"TotalPlanCost": 201832, | |
"Month9_Patient": 500, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 16861, | |
"Month8_Plan": 16861, | |
"Month7_Patient": 500, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6018, | |
"Month4_Plan": 16861, | |
"Month5_Patient": 500, | |
"Month7_Plan": 16861, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 16861, | |
"Month10_Patient": 500, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 190821, | |
"ProductName": "Sutent", | |
"Month11_Patient": 0, | |
"Lives": 11891, | |
"TherapyInitiation_Patient": 6500, | |
"DrugTier": "4", | |
"MedDed": 6000, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17361, | |
"PlanType": "EPO", | |
"Month11_Plan": 17361, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17361, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 150, | |
"TherapyInitiation_Plan": 10861, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 17361, | |
"Month2_Patient": 150, | |
"Month3_Plan": 17361, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze 60 D HDHP EPO", | |
"Month9_Plan": 17361, | |
"TotalPlanCost": 201682, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 17211, | |
"Month8_Plan": 17361, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6019, | |
"Month4_Plan": 17361, | |
"Month5_Patient": 0, | |
"Month7_Plan": 17361, | |
"MedOOP": 6650, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 17361, | |
"Month10_Patient": 0, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 188821, | |
"ProductName": "Sutent", | |
"Month11_Patient": 0, | |
"Lives": 782, | |
"TherapyInitiation_Patient": 5750, | |
"DrugTier": "4", | |
"MedDed": 5250, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 16861, | |
"PlanType": "EPO", | |
"Month11_Plan": 17361, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17361, | |
"Month6_Patient": 150, | |
"TherapyContinuation_Patient": 2150, | |
"TherapyInitiation_Plan": 11611, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 17211, | |
"Month2_Patient": 500, | |
"Month3_Plan": 16861, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5250", | |
"Month9_Plan": 17361, | |
"TotalPlanCost": 200432, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 16861, | |
"Month8_Plan": 17361, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6020, | |
"Month4_Plan": 16861, | |
"Month5_Patient": 500, | |
"Month7_Plan": 17361, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 17361, | |
"Month10_Patient": 0, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 189421, | |
"ProductName": "Sutent", | |
"Month11_Patient": 0, | |
"Lives": 1773, | |
"TherapyInitiation_Patient": 6350, | |
"DrugTier": "4", | |
"MedDed": 5850, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17311, | |
"PlanType": "EPO", | |
"Month11_Plan": 17361, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17361, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1550, | |
"TherapyInitiation_Plan": 11011, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 17361, | |
"Month2_Patient": 500, | |
"Month3_Plan": 16861, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 5850", | |
"Month9_Plan": 17361, | |
"TotalPlanCost": 200432, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 16861, | |
"Month8_Plan": 17361, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6021, | |
"Month4_Plan": 16861, | |
"Month5_Patient": 50, | |
"Month7_Plan": 17361, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 17361, | |
"Month10_Patient": 0, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 190471, | |
"ProductName": "Sutent", | |
"Month11_Patient": 0, | |
"Lives": 1100, | |
"TherapyInitiation_Patient": 7400, | |
"DrugTier": "4", | |
"MedDed": 6900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17361, | |
"PlanType": "EPO", | |
"Month11_Plan": 17361, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17361, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 500, | |
"TherapyInitiation_Plan": 9961, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 17361, | |
"Month2_Patient": 500, | |
"Month3_Plan": 17361, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze Pathway EPO 6900 Online Plus", | |
"Month9_Plan": 17361, | |
"TotalPlanCost": 200432, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 16861, | |
"Month8_Plan": 17361, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6022, | |
"Month4_Plan": 17361, | |
"Month5_Patient": 0, | |
"Month7_Plan": 17361, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 17361, | |
"Month10_Patient": 0, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 188221, | |
"ProductName": "Sutent", | |
"Month11_Patient": 250, | |
"Lives": 2373, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17111, | |
"PlanType": "EPO", | |
"Month11_Plan": 17111, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17111, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 17111, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 17111, | |
"Month2_Patient": 250, | |
"Month3_Plan": 17111, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Gold 80 D EPO", | |
"Month9_Plan": 17111, | |
"TotalPlanCost": 205332, | |
"Month9_Patient": 250, | |
"MetalLevel": "Gold", | |
"Month2_Plan": 17111, | |
"Month8_Plan": 17111, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6023, | |
"Month4_Plan": 17111, | |
"Month5_Patient": 250, | |
"Month7_Plan": 17111, | |
"MedOOP": 7200, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 17111, | |
"Month10_Patient": 250, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 190971, | |
"ProductName": "Sutent", | |
"Month11_Patient": 0, | |
"Lives": 1594, | |
"TherapyInitiation_Patient": 7900, | |
"DrugTier": "4", | |
"MedDed": 7900, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17361, | |
"PlanType": "EPO", | |
"Month11_Plan": 17361, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17361, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 0, | |
"TherapyInitiation_Plan": 9461, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 17361, | |
"Month2_Patient": 0, | |
"Month3_Plan": 17361, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"PlanName": "Anthem Minimum Coverage D EPO", | |
"Month9_Plan": 17361, | |
"TotalPlanCost": 200432, | |
"Month9_Patient": 0, | |
"MetalLevel": "Catastrophic", | |
"Month2_Plan": 17361, | |
"Month8_Plan": 17361, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6024, | |
"Month4_Plan": 17361, | |
"Month5_Patient": 0, | |
"Month7_Plan": 17361, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 17361, | |
"Month10_Patient": 0, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 188221, | |
"ProductName": "Sutent", | |
"Month11_Patient": 250, | |
"Lives": 1040, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17111, | |
"PlanType": "EPO", | |
"Month11_Plan": 17111, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17111, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 17111, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 17111, | |
"Month2_Patient": 250, | |
"Month3_Plan": 17111, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Platinum 90 D EPO", | |
"Month9_Plan": 17111, | |
"TotalPlanCost": 205332, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 17111, | |
"Month8_Plan": 17111, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6025, | |
"Month4_Plan": 17111, | |
"Month5_Patient": 250, | |
"Month7_Plan": 17111, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 17111, | |
"Month10_Patient": 250, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 188221, | |
"ProductName": "Sutent", | |
"RxDed": 200, | |
"Month11_Patient": 250, | |
"Lives": 44655, | |
"TherapyInitiation_Patient": 450, | |
"DrugTier": "4", | |
"MedDed": 2500, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17111, | |
"PlanType": "EPO", | |
"Month11_Plan": 17111, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17111, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 16911, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 17111, | |
"Month2_Patient": 250, | |
"Month3_Plan": 17111, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=kwvbqPaimJM%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Anthem Silver 70 Off Exchange EPO", | |
"Month9_Plan": 17111, | |
"TotalPlanCost": 205132, | |
"Month9_Patient": 250, | |
"MetalLevel": "Silver", | |
"Month2_Plan": 17111, | |
"Month8_Plan": 17111, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6026, | |
"Month4_Plan": 17111, | |
"Month5_Patient": 250, | |
"Month7_Plan": 17111, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 17111, | |
"Month10_Patient": 250, | |
"DrugId": 66 | |
}, { | |
"TherapyContinuation_Plan": 189171, | |
"ProductName": "Sutent", | |
"Month11_Patient": 0, | |
"Lives": 7081, | |
"TherapyInitiation_Patient": 6100, | |
"DrugTier": "4", | |
"MedDed": 5600, | |
"DedType": "Medical", | |
"TotalPayerLives": 413387, | |
"Month5_Plan": 17061, | |
"PlanType": "PPO", | |
"Month11_Plan": 17361, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 17361, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 1800, | |
"TherapyInitiation_Plan": 11261, | |
"TotalTiers": "5", | |
"Month4_Patient": 500, | |
"Month6_Plan": 17361, | |
"Month2_Patient": 500, | |
"Month3_Plan": 16861, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=9xPV65t4mAk%24", | |
"Insurer": "Anthem Blue Cross of California", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Anthem Bronze PPO 40/5600/40%", | |
"Month9_Plan": 17361, | |
"TotalPlanCost": 200432, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 16861, | |
"Month8_Plan": 17361, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 8, | |
"BDId": 6027, | |
"Month4_Plan": 16861, | |
"Month5_Patient": 300, | |
"Month7_Plan": 17361, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G (1a/1b), PB, NPG/NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 17361, | |
"Month10_Patient": 0, | |
"DrugId": 66 | |
}]; | |
export const VOTRIENT = [{ | |
"TherapyContinuation_Plan": 136422, | |
"ProductName": "Votrient", | |
"Month11_Patient": 250, | |
"Lives": 1006, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12402, | |
"PlanType": "HMO", | |
"Month11_Plan": 12402, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12402, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 12402, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 12402, | |
"Month2_Patient": 250, | |
"Month3_Plan": 12402, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Sharp Platinum 90 HMO Performance", | |
"Month9_Plan": 12402, | |
"TotalPlanCost": 148824, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 12402, | |
"Month8_Plan": 12402, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12158, | |
"Month4_Plan": 12402, | |
"Month5_Patient": 250, | |
"Month7_Plan": 12402, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 12402, | |
"Month10_Patient": 250, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 136422, | |
"ProductName": "Votrient", | |
"Month11_Patient": 250, | |
"Lives": 1404, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12402, | |
"PlanType": "HMO", | |
"Month11_Plan": 12402, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12402, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 12402, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 12402, | |
"Month2_Patient": 250, | |
"Month3_Plan": 12402, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Sharp Platinum 90 HMO Premier", | |
"Month9_Plan": 12402, | |
"TotalPlanCost": 148824, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 12402, | |
"Month8_Plan": 12402, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12159, | |
"Month4_Plan": 12402, | |
"Month5_Patient": 250, | |
"Month7_Plan": 12402, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 12402, | |
"Month10_Patient": 250, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 136422, | |
"ProductName": "Votrient", | |
"Month11_Patient": 250, | |
"Lives": 2292, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12402, | |
"PlanType": "HMO", | |
"Month11_Plan": 12402, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12402, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 12402, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 12402, | |
"Month2_Patient": 250, | |
"Month3_Plan": 12402, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Sharp Gold 80 HMO Performance", | |
"Month9_Plan": 12402, | |
"TotalPlanCost": 148824, | |
"Month9_Patient": 250, | |
"MetalLevel": "Gold", | |
"Month2_Plan": 12402, | |
"Month8_Plan": 12402, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12160, | |
"Month4_Plan": 12402, | |
"Month5_Patient": 250, | |
"Month7_Plan": 12402, | |
"MedOOP": 7200, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 12402, | |
"Month10_Patient": 250, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 136422, | |
"ProductName": "Votrient", | |
"Month11_Patient": 250, | |
"Lives": 2721, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12402, | |
"PlanType": "HMO", | |
"Month11_Plan": 12402, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12402, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 12402, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 12402, | |
"Month2_Patient": 250, | |
"Month3_Plan": 12402, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Sharp Gold 80 HMO Premier", | |
"Month9_Plan": 12402, | |
"TotalPlanCost": 148824, | |
"Month9_Patient": 250, | |
"MetalLevel": "Gold", | |
"Month2_Plan": 12402, | |
"Month8_Plan": 12402, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12161, | |
"Month4_Plan": 12402, | |
"Month5_Patient": 250, | |
"Month7_Plan": 12402, | |
"MedOOP": 7200, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 12402, | |
"Month10_Patient": 250, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 136422, | |
"ProductName": "Votrient", | |
"RxDed": 200, | |
"Month11_Patient": 250, | |
"Lives": 2807, | |
"TherapyInitiation_Patient": 450, | |
"DrugTier": "4", | |
"MedDed": 2500, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12402, | |
"PlanType": "HMO", | |
"Month11_Plan": 12402, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12402, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 12202, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 12402, | |
"Month2_Patient": 250, | |
"Month3_Plan": 12402, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Sharp Silver 70 Off Exchange HMO Premier", | |
"Month9_Plan": 12402, | |
"TotalPlanCost": 148624, | |
"Month9_Patient": 250, | |
"MetalLevel": "Silver", | |
"Month2_Plan": 12402, | |
"Month8_Plan": 12402, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12162, | |
"Month4_Plan": 12402, | |
"Month5_Patient": 250, | |
"Month7_Plan": 12402, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 12402, | |
"Month10_Patient": 250, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 133672, | |
"ProductName": "Votrient", | |
"RxDed": 500, | |
"Month11_Patient": 500, | |
"Lives": 6830, | |
"TherapyInitiation_Patient": 1000, | |
"DrugTier": "4", | |
"MedDed": 6300, | |
"DedType": "Pharmacy", | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12152, | |
"PlanType": "HMO", | |
"Month11_Plan": 12152, | |
"Month8_Patient": 500, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12152, | |
"Month6_Patient": 500, | |
"TherapyContinuation_Patient": 5500, | |
"TherapyInitiation_Plan": 11652, | |
"TotalTiers": "4", | |
"Month4_Patient": 500, | |
"Month6_Plan": 12152, | |
"Month2_Patient": 500, | |
"Month3_Plan": 12152, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 500, | |
"CBMax": 500, | |
"PlanName": "Sharp Bronze 60 HMO Performance", | |
"Month9_Plan": 12152, | |
"TotalPlanCost": 145324, | |
"Month9_Patient": 500, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 12152, | |
"Month8_Plan": 12152, | |
"Month7_Patient": 500, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12163, | |
"Month4_Plan": 12152, | |
"Month5_Patient": 500, | |
"Month7_Plan": 12152, | |
"MedOOP": 7550, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 500, | |
"Month10_Plan": 12152, | |
"Month10_Patient": 500, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 139022, | |
"ProductName": "Votrient", | |
"Month11_Patient": 0, | |
"Lives": 2900, | |
"TherapyInitiation_Patient": 6500, | |
"DrugTier": "4", | |
"MedDed": 6000, | |
"DedType": "Medical", | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12652, | |
"PlanType": "HMO", | |
"Month11_Plan": 12652, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12652, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 150, | |
"TherapyInitiation_Plan": 6152, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 12652, | |
"Month2_Patient": 150, | |
"Month3_Plan": 12652, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 0, | |
"CBMax": 500, | |
"PlanName": "Sharp Bronze 60 HDHP HMO Premier", | |
"Month9_Plan": 12652, | |
"TotalPlanCost": 145174, | |
"Month9_Patient": 0, | |
"MetalLevel": "Bronze", | |
"Month2_Plan": 12502, | |
"Month8_Plan": 12652, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12164, | |
"Month4_Plan": 12652, | |
"Month5_Patient": 0, | |
"Month7_Plan": 12652, | |
"MedOOP": 6650, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 12652, | |
"Month10_Patient": 0, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 139172, | |
"ProductName": "Votrient", | |
"Month11_Patient": 0, | |
"Lives": 212, | |
"TherapyInitiation_Patient": 7900, | |
"DrugTier": "4", | |
"MedDed": 7900, | |
"DedType": "Medical", | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12652, | |
"PlanType": "HMO", | |
"Month11_Plan": 12652, | |
"Month8_Patient": 0, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12652, | |
"Month6_Patient": 0, | |
"TherapyContinuation_Patient": 0, | |
"TherapyInitiation_Plan": 4752, | |
"TotalTiers": "4", | |
"Month4_Patient": 0, | |
"Month6_Plan": 12652, | |
"Month2_Patient": 0, | |
"Month3_Plan": 12652, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=RFU9lBeJklo%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 0, | |
"PlanName": "Sharp Minimum Coverage HMO Performance", | |
"Month9_Plan": 12652, | |
"TotalPlanCost": 143924, | |
"Month9_Patient": 0, | |
"MetalLevel": "Catastrophic", | |
"Month2_Plan": 12652, | |
"Month8_Plan": 12652, | |
"Month7_Patient": 0, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12165, | |
"Month4_Plan": 12652, | |
"Month5_Patient": 0, | |
"Month7_Plan": 12652, | |
"MedOOP": 7900, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 0, | |
"Month10_Plan": 12652, | |
"Month10_Patient": 0, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 136422, | |
"ProductName": "Votrient", | |
"Month11_Patient": 250, | |
"Lives": 97, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12402, | |
"PlanType": "HMO", | |
"Month11_Plan": 12402, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12402, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 12402, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 12402, | |
"Month2_Patient": 250, | |
"Month3_Plan": 12402, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=2AwzVj%2fOKhU%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Sharp Performance Platinum 90 HMO 0-15 + Child Dental", | |
"Month9_Plan": 12402, | |
"TotalPlanCost": 148824, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 12402, | |
"Month8_Plan": 12402, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12185, | |
"Month4_Plan": 12402, | |
"Month5_Patient": 250, | |
"Month7_Plan": 12402, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 12402, | |
"Month10_Patient": 250, | |
"DrugId": 68 | |
}, { | |
"TherapyContinuation_Plan": 136422, | |
"ProductName": "Votrient", | |
"Month11_Patient": 250, | |
"Lives": 103, | |
"TherapyInitiation_Patient": 250, | |
"DrugTier": "4", | |
"MedDed": 0, | |
"TotalPayerLives": 40619, | |
"Month5_Plan": 12402, | |
"PlanType": "HMO", | |
"Month11_Plan": 12402, | |
"Month8_Patient": 250, | |
"PlanYear": "Jan 1, 2019", | |
"CoverageType": "Pharmacy", | |
"Month12_Plan": 12402, | |
"Month6_Patient": 250, | |
"TherapyContinuation_Patient": 2750, | |
"TherapyInitiation_Plan": 12402, | |
"TotalTiers": "4", | |
"Month4_Patient": 250, | |
"Month6_Plan": 12402, | |
"Month2_Patient": 250, | |
"Month3_Plan": 12402, | |
"State": "CA", | |
"Link": "http://wpso.dmhc.ca.gov/premiumratereview/filingdetails?id=2AwzVj%2fOKhU%24", | |
"Insurer": "Sharp Health Plan", | |
"Month12_Patient": 250, | |
"CBMax": 250, | |
"PlanName": "Sharp Premier Platinum 90 HMO 0-15 + Child Dental", | |
"Month9_Plan": 12402, | |
"TotalPlanCost": 148824, | |
"Month9_Patient": 250, | |
"MetalLevel": "Platinum", | |
"Month2_Plan": 12402, | |
"Month8_Plan": 12402, | |
"Month7_Patient": 250, | |
"Notes": "Projected member months. Reported in member months so divided by 12", | |
"ParentId": 134, | |
"BDId": 12186, | |
"Month4_Plan": 12402, | |
"Month5_Patient": 250, | |
"Month7_Plan": 12402, | |
"MedOOP": 3350, | |
"TA": "Renal Cell Carcinoma", | |
"TierDescrip": "G, NPG/PB, NPB, S", | |
"FileType": "URRT", | |
"Month3_Patient": 250, | |
"Month10_Plan": 12402, | |
"Month10_Patient": 250, | |
"DrugId": 68 | |
}]; |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment